Wenbin Jiang Cytek Biosciences, Inc. (CTKB) insider trading activity

Wenbin Jiang is PRESIDENT AND CEO of Cytek Biosciences, Inc.. Currently has a direct ownership of 5.26 Million shares of CTKB, which is worth approximately $17.6 Million. The most recent transaction as insider was on May 18, 2022, when has been sold 9,011 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.26M

0.7% 3M change

1.21% 12M change

Total Value Held $17.6 Million

Wenbin Jiang Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 18 2022	BUY Exercise of conversion of derivative security	-	9,011 Added 0.11%	7,905,051 Common Stock
May 09 2022	SELL Open market or private sale	$160,200 $8.01 p/Share	20,000 Reduced 0.25%	7,896,040 Common Stock
Apr 07 2022	SELL Open market or private sale	$210,800 $10.54 p/Share	20,000 Reduced 0.25%	7,916,040 Common Stock
Mar 07 2022	SELL Open market or private sale	$263,800 $13.19 p/Share	20,000 Reduced 0.25%	7,936,040 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	$16,666 $0.25 p/Share	66,665 Added 0.83%	7,956,040 Common Stock
Feb 07 2022	SELL Open market or private sale	$288,000 $14.4 p/Share	20,000 Reduced 0.25%	7,889,375 Common Stock
Dec 04 2021	SELL Bona fide gift	-	5,000 Reduced 0.06%	7,842,710 Common Stock

Wenbin Jiang

PRESIDENT AND CEO

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Value

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB

Account